-

Surge Private Equity Closes Investment into Amuze Products

DALLAS--(BUSINESS WIRE)--Surge Private Equity LLC (“Surge”) announces its investment into Amuze Products II Inc. (“Amuze”), a Dallas-based massage chair and hurricane simulator operator. The transaction closed with debt financing provided by CrowdOut Capital LLC.

For almost a decade, Amuze has developed proprietary, customized, electronic massage chairs and hurricane simulators featuring in-house live telemetry monitoring and maintenance services primarily for trampoline parks, amusement parks, and truck stops. Clients can generate additional revenue in otherwise unused space hassle and investment free by allowing Amuze to install, maintain, and monitor Amuze’s massage chairs and other vending products under a revenue sharing agreement. To date, Amuze has placed over 3,000 chairs across all 50 states. Founder Phillip Brothers will retain equity in the business and remain as CEO. Surge is looking to support Amuze with growth capital, future add-on acquisition campaigns, and new product line expansions.

Tom Beauchamp, Founding Partner at Surge, stated, “Phil and I have been in touch for years now with the aim of partnering up. As the company has bounced back from COVID levels and resumed its growth rate, we were finally able to make it happen. With 95% recurring revenue, a very diverse customer base including multiple blue chip corporations, and a five-year revenue CAGR over 50%, Phil has built a very attractive company. We are eager to work with him and the company to help continue the growth trajectory.”

About Surge Private Equity LLC

Surge Private Equity is a Dallas-based private equity firm that typically seeks majority investments in growing businesses with $2-7.5MM of EBITDA. Together with its lending partners, Surge provides entrepreneurs with liquidity and investors with higher yields and greater accessibility through lower investment minimums. Surge primarily invests in companies where the seller will remain in an ongoing capacity.

About CrowdOut Capital LLC

CrowdOut Capital is a leading private lender to lower middle-market companies. CrowdOut’s network of experienced owner-operators and industry veterans provide exclusive deal opportunities and key insights during underwriting and diligence. In addition to access to needed capital, borrowers benefit from the proprietary knowledge of CrowdOut's connected network of investors. CrowdOut has led more than $315 million in originations since inception.

Contacts

William Wright
WWright@SurgePE.com
214-317-6263

Surge Private Equity LLC


Release Versions

Contacts

William Wright
WWright@SurgePE.com
214-317-6263

More News From Surge Private Equity LLC

Surge PE Closes Investment Into White Plains Linen

DALLAS--(BUSINESS WIRE)--On August 1st, 2025 Surge Private Equity LLC (“Surge”) closed on its investment into White Plains Linen (“WPL”), a leading provider of commercial laundry services based in Peekskill, New York. The transaction, valued over $50MM, closed with debt financing provided by Capital Southwest Corporation. Jackson Walker LLP acted as lead counsel to Surge, and Moss Adams/Baker Tilly provided financial diligence for the transaction. IMG Business Advisors acted as lead advisor for...

Surge Private Equity Closes Investment into Coastal Amusements

DALLAS--(BUSINESS WIRE)--On December 1st, 2023, Dallas-based Surge Private Equity, LLC (“Surge”) closed an investment into Coastal Amusements, Inc. (“Coastal” or the “Company”), a leading designer, manufacturer, and importer of coin-operated ticket and prize redemption games headquartered in New Jersey. NorthCoast Mezzanine and Minnesota Bank & Trust provided financing to complete the transaction. BakerHostetler and Moss Adams acted as lead counsel and financial diligence advisor, respectiv...

SurgePE Closes Elite Clinical Network Investment

DALLAS--(BUSINESS WIRE)--On September 8th, 2023, Dallas-based Surge Private Equity, LLC (“Surge”) announced that it has formed a new strategic partnership with Elite Clinical Network, LLC (“ECN” or the “Company”), an integrated platform currently operating a network of phase I-IV clinical research sites throughout California, Arizona, and Nevada that has completed thousands of studies. The transaction, valued at ~$200MM, closed with debt financing provided by affiliates of MGG Investment Group...
Back to Newsroom